Autologous versus allogeneic mesenchymal stem cell therapy: The pros and cons

Nisha Durand; Abba C. Zubair

doi:10.1016/j.surg.2021.10.057

Autologous versus allogeneic mesenchymal stem cell therapy: The pros and cons

Laboratory Medicine and Pathology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1440-1442
Number of pages	3
Journal	Surgery (United States)
Volume	171
Issue number	5
DOIs	https://doi.org/10.1016/j.surg.2021.10.057
State	Published - May 2022

ASJC Scopus subject areas

Surgery

Access to Document

10.1016/j.surg.2021.10.057

Cite this

@article{8b0fd213fb2441f8be4a1b6d0cc25cbc,

title = "Autologous versus allogeneic mesenchymal stem cell therapy: The pros and cons",

author = "Nisha Durand and Zubair, {Abba C.}",

note = "Funding Information: We would like to thank the Mayo Clinic Center for Regenerative Medicine for funding support.",

year = "2022",

month = may,

doi = "10.1016/j.surg.2021.10.057",

language = "English (US)",

volume = "171",

pages = "1440--1442",

journal = "Surgery (United States)",

issn = "0039-6060",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Autologous versus allogeneic mesenchymal stem cell therapy

T2 - The pros and cons

AU - Durand, Nisha

AU - Zubair, Abba C.

N1 - Funding Information: We would like to thank the Mayo Clinic Center for Regenerative Medicine for funding support.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85120447371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120447371&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2021.10.057

DO - 10.1016/j.surg.2021.10.057

M3 - Article

C2 - 34863523

AN - SCOPUS:85120447371

SN - 0039-6060

VL - 171

SP - 1440

EP - 1442

JO - Surgery (United States)

JF - Surgery (United States)

IS - 5

ER -

Autologous versus allogeneic mesenchymal stem cell therapy: The pros and cons

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this